Connect with us

Healthcare

Jury Finds Theranos Founder Elizabeth Holmes Guilty of Fraud

Published

on

Elizabeth Holmes, the former Theranos CEO who promised to revolutionize medicine but whose company collapsed under the weight of its many misrepresentations, was found guilty of fraud on Monday, capping a years-long saga that came to symbolize Silicon Valley hubris.

After seven days of deliberations, a federal jury found Holmes, 37, guilty of defrauding investors while raising money for Theranos. Holmes was convicted of conspiracy to defraud investors and three counts of wire fraud. The jury found her not guilty of conspiring to defraud patients and cleared her on two individual patient-related charges and one count of lying in paid advertisements. The jury couldn’t reach a unanimous verdict on three counts of defrauding individual investors, possibly leaving the door open for a retrial on those specific charges.

Read the rest…

Original Post: statnews.com

Healthcare

Budapest Tram Displays Children’s Paintings of Beijing 2022

Published

on

BUDAPEST, Jan. 20 (Xinhua) — In Budapest, a colorful tram has attracted the attention of local citizens, as it carries the vision of the Beijing Winter Olympics drawn by Hungarian children, on a constantly moving display from January 20 to February 10.

The children’s paintings are part of the mobile exhibition entitled “The Winter Olympics I yearn for,” and will shuttle through the Margaret Bridge, the Petofi B

Original Post: bignewsnetwork.com

Continue Reading

Healthcare

‘The Scientists, They’re Learning More’: a Defiant Biden Defends the CDC Amid Mounting Criticism

Published

on

WASHINGTON — President Biden on Wednesday defended the Centers for Disease Control and Prevention, amid mounting criticism of the agency’s repeated struggles to communicate basic public health guidance.

But instead of conceding that the agency is fundamentally flawed, or that his top health officials have underperformed, Biden attributed the communications issues to the ever-changing nature of the Covid-19 pandemic, and of science itself.

Read the rest…

Source: statnews.com

Continue Reading

Healthcare

Regenerative Med Biotech ProKidney Inks $825M Merger to Back CKD Cell Therapy

Published

on

ProKidney is going public in a SPAC merger that infuses the biotech with $825 million for Phase 3 tests and manufacturing of its autologous cell therapy for chronic kidney disease. More than slowing the decline in organ function, ProKidney says its cell therapy offers the potential to reverse injury caused by the condition.

Original Post: medcitynews.com

Continue Reading

Trending

Top100Biz.com